<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20090301001722N27</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-29</date_registration>
      <primary_sponsor>Shifa Tameer e Millat University</primary_sponsor>
      <public_title>Effect of whole-body vibration in children with cerebral palsy</public_title>
      <acronym></acronym>
      <scientific_title>Effects of Whole-Body Vibration Therapy in Weight-Bearing and Non-Weight Bearing positions for Upper and Lower Extremities on Balance and Function in Cerebral Palsy children.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64165</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Before the process of randomization, we will screen all the participants and assign them a unique number from 1 to 60. Then the process of randomization will be carried out using Random Allocation software version 1.0 (developed by the Department of Anaesthesia, Isfahan University of Medical Sciences, Isfahan, Iran). It is a randomization software for parallel group trials. It requires the total sample size and the total number of groups. We will add a total sample size of 60 participants and 6 groups into the software with only one block. The software generates an output file that can be opened with internet explorer. The output file contains a list of number along with assigned groups. In our case, the groups will be Aa, Ab, Ac, Ba, Bb, and Bc with 10 participants in each group. Then this sequence will be used for participant allocation in the study groups, Blinding description: The care provider will be blinded to the groups of the study  (i.e. Treatment and Control Group). While the outcome assessors will be blinded to the treatment protocols and study hypothesis.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cerebral Palsy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 1. The Whole-body vibration therapy in weight-bearing (WBV-WB) lower extremity group will receive the WBV training for 20 min a day, 3 days a week for a 4-week period. The children assigned to the WBV-WB group will be instructed to maintain a standing posture on a vibration platform. Children will stand barefooted with feet parallel and knees straight or in slight flexion (30°). The feet will be placed in an equal distance from the center line of the device when standing. During the 20 min of therapy, every 3 minute of vibration training and 2 minutes of rest will be repeated 4 times. The frequency of the WBV stimulation will be (12–18 Hz) and will achieved gradually increasing 1 Hz per 2 seconds, till the desired frequency is achieved. Intervention 2: Intervention group: 2. The Whole-body vibration therapy in weight-bearing (WBV-WB) upper extremity group will receive the same protocol like Lower Extremity, but in a kneeling quadruped position with the hands-on the platform. Intervention 3: Intervention group: 3. The Whole-body vibration therapy in weight-bearing (WBV-WB) combine upper and lower extremity group will receive same protocol like (Upper and Lower Extremity Protocol Mentioned above) in standing on one whole-body vibrator while leaning on the other whole-body vibrator with hands. A total of 2 Whole body vibration units will be used simultaneously. Intervention 4: Intervention group: 4. The Whole-body vibration therapy in non weight-bearing (WBV-NWB) lower extremity group will receive the WBV training for 20 min a day, 3 days a week for a 4-week period. The children assigned to the WBV-NWB group will be instructed to maintain seated posture on a chair. Children will place their feet on the whole-body vibrator. During the 20 min of therapy, every 3 minute of vibration training and 2 minutes of rest will be repeated 4 times. The frequency of the WBV stimulation will be (12–18 Hz) and will achieved gradually increasing 1 Hz per 2 seconds, till the desired frequency is achieved. Intervention 5: Intervention group: 5.  The Whole-body vibration therapy in non weight-bearing (NWBV-WB) upper extremity group will receive the same protocol like Lower Extremity, but in seated position with  the hands-on on the platform. Intervention 6: Intervention group: 6. The Whole-body vibration therapy in non weight-bearing (NWBV-WB) combine upper and lower extremity group will receive same protocol like (Upper and Lower Extremity Protocol Mentioned above) in seated position. One platform will be under the feet and the other will be under the hands. A total of 2 Whole body vibration units will be used simultaneously.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Currently we are working on streamlining the project and data collection. After recruiting the participants we may be able to deidentify individual data sets.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Mohammad-Reza Hadian Rasanani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation Faculty, Pich e Shemiran, Enghelab Street Tehran Tehran Iran,</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1417614411</zip>
        <telephone>+98 21 8891 3469</telephone>
        <email>hadianrasan@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mohammad Reza Hadian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation faculty, pich e shemiran, enghlab street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965141</zip>
        <telephone>+98 21 7753 6134</telephone>
        <email>hadianrs@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age of 5-15 years.
Both Genders (Boys and Girls)
With a diagnosis of spastic cerebral palsy.
Degree of Spasticity Grade 1, 1+ and 2 according to Modified Ashworth Scale.
Mild Severity of cerebral palsy
Level I and II of Gross Motor Function Classification System</inclusion_criteria>
      <agemin>5 years</agemin>
      <agemax>15 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Children with fixed musculoskeletal deformities
With a history of recent surgery (less than 1 year)
Unhealed fractures
Any case of epilepsy or visual or auditory problems
Under treatment with botulinum toxin
Non-Spastic cerebral palsy (Ataxic, Dyskinetic etc.)
Children having Sensory loss in upper and lower extremity.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G80</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral palsy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 1. The Whole-body vibration therapy in weight-bearing (WBV-WB) lower extremity group will receive the WBV training for 20 min a day, 3 days a week for a 4-week period. The children assigned to the WBV-WB group will be instructed to maintain a standing posture on a vibration platform. Children will stand barefooted with feet parallel and knees straight or in slight flexion (30°). The feet will be placed in an equal distance from the center line of the device when standing. During the 20 min of therapy, every 3 minute of vibration training and 2 minutes of rest will be repeated 4 times. The frequency of the WBV stimulation will be (12–18 Hz) and will achieved gradually increasing 1 Hz per 2 seconds, till the desired frequency is achieved.</i_keyword>
      <i_keyword>Intervention group: 2. The Whole-body vibration therapy in weight-bearing (WBV-WB) upper extremity group will receive the same protocol like Lower Extremity, but in a kneeling quadruped position with the hands-on the platform.</i_keyword>
      <i_keyword>Intervention group: 3. The Whole-body vibration therapy in weight-bearing (WBV-WB) combine upper and lower extremity group will receive same protocol like (Upper and Lower Extremity Protocol Mentioned above) in standing on one whole-body vibrator while leaning on the other whole-body vibrator with hands. A total of 2 Whole body vibration units will be used simultaneously.</i_keyword>
      <i_keyword>Intervention group: 4. The Whole-body vibration therapy in non weight-bearing (WBV-NWB) lower extremity group will receive the WBV training for 20 min a day, 3 days a week for a 4-week period. The children assigned to the WBV-NWB group will be instructed to maintain seated posture on a chair. Children will place their feet on the whole-body vibrator. During the 20 min of therapy, every 3 minute of vibration training and 2 minutes of rest will be repeated 4 times. The frequency of the WBV stimulation will be (12–18 Hz) and will achieved gradually increasing 1 Hz per 2 seconds, till the desired frequency is achieved.</i_keyword>
      <i_keyword>Intervention group: 5.  The Whole-body vibration therapy in non weight-bearing (NWBV-WB) upper extremity group will receive the same protocol like Lower Extremity, but in seated position with  the hands-on on the platform.</i_keyword>
      <i_keyword>Intervention group: 6. The Whole-body vibration therapy in non weight-bearing (NWBV-WB) combine upper and lower extremity group will receive same protocol like (Upper and Lower Extremity Protocol Mentioned above) in seated position. One platform will be under the feet and the other will be under the hands. A total of 2 Whole body vibration units will be used simultaneously.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Modified Ashworth Scale. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: Modified Ashworth Scale Questionnaire.</prim_outcome>
      <prim_outcome>Timed up and go test. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: One Chair, Measurement Tape and Stop Watch.</prim_outcome>
      <prim_outcome>Pediatric Balance Scale. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: Pediatric Balance Scale Questionnaire.</prim_outcome>
      <prim_outcome>MFT balance score. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: MFT Balance Disc 2.0.</prim_outcome>
      <prim_outcome>Jebsen-Taylor Hand Function Test. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: Writing a short sentence (24 letters, 3rd grade reading difficulty)Turning over a 3×5-inch card,Picking up small common objects (coins, paper clips and metal bottle caps) and transferring them into a container,Simulated feeding (by collecting beans with a spoon and transferring them into a container),Stacking checkers,Picking up and transferring large light objects (empty cans)Picking up and transferring large heavy objects (cans with weight of 0.453 kg). The subtests are scored by recording the number of seconds required to complete each test.</prim_outcome>
      <prim_outcome>Hand Grip Strength. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: Hand Held Digital Dynamometer.</prim_outcome>
      <prim_outcome>Joint Range of motion. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: Universal Goniometer.</prim_outcome>
      <prim_outcome>Cervical Joint Position Sense Error Test. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: Laser Tracker System.</prim_outcome>
      <prim_outcome>Center of Pressure of Both Feet. Timepoint: Before and After the intervention for Upper Limb and lower limb in weight bearing and non weight bearing position. Method of measurement: BWT-61 CL Digital Gyroscope.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shifa Tameer e Millat University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-05-14</approval_date>
        <contact_name>Tehran University of Medical Sciences (TUMS)</contact_name>
        <contact_address>School of Rehabilitation of Tehran University of Medical Sciences, Piche Shemiran, Enghelab Ave, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
